MLICM
PEAR

Metropolitan Life Insurance Company (MetLife)’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,946
Closed -$5.84K – 2510
2022
Q4 		$5.84K Buy
+4,946
New +$5.84K ﹤0.01% 2351